Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q1 Trading Update

22 Sep 2022 07:00

RNS Number : 2158A
Time Finance PLC
22 September 2022
 

22 September 2022

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Q1 Trading Statement

Positive trading momentum continues;

lending book grows; arrears continue to fall

 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to announce the Group's trading performance for the first quarter of the current financial year which ended on 30 August 2022.

 

Unaudited financial highlights:

 

· Own-Book lending origination up 26% to £15.7m (Q1 2021/22: £12.5m)

· Revenue up 12% to £6.3m (Q1 2021/22: £5.6m)

· Profit before Tax up 125% to £0.9m (Q1 2021/22: £0.4m)

· The lending-book continued to grow; increasing 4% to £142.8m since year-end (31 May 2022: £136.8m) and 24% from 12 months prior (30 August 2021: £115.0m)

· Net Arrears continued to fall; reducing 1% since year-end to £9.2m (31 May 2022: £9.3m) and 36% from 12 months prior (30 August 2021: £14.3m)

· Net Tangible Assets continued to increase; up 3% since year-end to £31.3m (31 May 2022: £30.5m) and 9% from 12 months prior (30 August 2021: £28.8m)

 

The increase in revenue is driven by solid growth in the lending book, particularly within the Invoice Finance division and the 'Hard' part of the Asset division. Both areas operate very much in the secured lending arena, reflecting the strategic desire for the Group to increase its average deal size and, where appropriate, take additional security on its lending.

 

Ed Rimmer, Chief Executive Officer commented:

 

"The first three months of the new financial year have seen the Group continue to experience growing levels of demand for finance from across the UK SME sector. This continued the momentum seen in the final quarter of the last financial year to 31 May 2022. The trend shows that the own-book lending strategy is becoming embedded within the Group, understood by our introducers and valued by UK businesses. The first quarter's unaudited results give the Board confidence that the Group is well positioned to build value for its shareholders".

 

The Board continues to expect the Group's trading for the full year to be in line with market expectations.

 

The Company will deliver a live presentation relating to this trading update and the simultaneously released 2022 Results announcement via the Investor Meet Company platform at 12.00pm BST today. Existing and potential shareholders can sign up to Investor Meet Company for free and add to meet Time Finance plc via: https://www.investormeetcompany.com/time-finance-plc/registerinvestor

 

 

 

 

 

For further information, please contact:

 

Time Finance plc

Ed Rimmer, Chief Executive Officer

01225 474230

James Roberts, Chief Financial Officer

01225 474230

Cenkos Securities plc (NOMAD and Broker)

Ben Jeynes / Max Gould (Corporate Finance)

Julian Morse (Sales)

0207 397 8900

Walbrook PR

0207 933 8780

Paul Vann / Joe Walker

07768 807631

timefinance@walbrookpr.com

 

About Time Finance:

Time Finance's core strategy is to focus on providing the finance UK SMEs require to fund their businesses. It offers a multi-product range for SMEs including asset, loan, invoice and vehicle finance. While primarily an 'own-book' lender the Group does operates a 'hybrid' lending and broking model enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website www.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFWFEESESU
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.